786 related articles for article (PubMed ID: 22397329)
1. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.
McCormack PL
Drugs; 2012 Mar; 72(5):585-617. PubMed ID: 22397329
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid: a review of its use in surgery and other indications.
Dunn CJ; Goa KL
Drugs; 1999 Jun; 57(6):1005-32. PubMed ID: 10400410
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid: a review of its use in the management of menorrhagia.
Wellington K; Wagstaff AJ
Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytics for heavy menstrual bleeding.
Lethaby A; Farquhar C; Cooke I
Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of inhibitors of fibrinolysis.
Verstraete M
Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid in trauma: how should we use it?
Roberts I
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S195-9. PubMed ID: 26149023
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
[TBL] [Abstract][Full Text] [Related]
9. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
[TBL] [Abstract][Full Text] [Related]
10. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid--an old drug still going strong and making a revival.
Tengborn L; Blombäck M; Berntorp E
Thromb Res; 2015 Feb; 135(2):231-42. PubMed ID: 25559460
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytics for heavy menstrual bleeding.
Cooke I; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2000; (2):CD000249. PubMed ID: 10796518
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytics in women with menorrhagia.
Philipp CS
Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.
Pabinger I; Fries D; Schöchl H; Streif W; Toller W
Wien Klin Wochenschr; 2017 May; 129(9-10):303-316. PubMed ID: 28432428
[TBL] [Abstract][Full Text] [Related]
15. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
16. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
Trials; 2010 Apr; 11():40. PubMed ID: 20398351
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.
Lukes AS; Moore KA; Muse KN; Gersten JK; Hecht BR; Edlund M; Richter HE; Eder SE; Attia GR; Patrick DL; Rubin A; Shangold GA
Obstet Gynecol; 2010 Oct; 116(4):865-875. PubMed ID: 20859150
[TBL] [Abstract][Full Text] [Related]
20. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
Ray S; Ray A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010338. PubMed ID: 27841443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
